下肢大截肢后长期死亡率:血管性或感染性肢体的当代分析
本研究回顾2020至2023年因慢性肢体威胁性缺血(CLTI)或严重感染行膝上或膝下大截肢的747例患者,中位随访1.2年。30天、1年和3年总生存率分别为91.9%、72.8%和49.0%。截肢相关死因仅占全部死亡的15.9%,总死亡风险因素包括高龄、膝上截肢、急诊手术及合并症。
要点
- 大截肢后3年生存率仅49.0%,长期预后仍较差。
- 截肢相关死因仅占15.9%,多数死亡源于合并症。
- 急诊截肢、膝上截肢、高龄及肾病是死亡风险因素。
核心结论
- 下肢大截肢后长期死亡率仍较高,但仅小部分死亡可归因于截肢手术或术后并发症。
- 总死亡风险因素包括高龄、急诊手术及严重合并症,应重视综合风险评估与预后沟通。
研究设计与样本
- 单中心回顾性队列研究,纳入2020至2023年因CLTI或严重感染行膝上或膝下大截肢的747例患者,中位随访1.2年。
- 采用Kaplan-Meier法评估生存率,Cox比例风险模型识别死亡风险因素。
主要发现
- 747例患者中,膝上截肢371例(49.7%),膝下截肢376例(50.3%),中位年龄65岁,男性占62.7%。
- 总体30天、1年和3年生存率分别为91.9%(95%CI 89.9-93.9%)、72.8%(95%CI 69.4-76.2%)和49.0%(95%CI 44.3-53.7%)。
- 截肢相关死因占全部死亡的15.9%,中位间隔为术后24天(四分位距8-64天)。
关键数值与推荐
- 总死亡风险因素:年龄(每增加1岁,HR 1.02,95%CI 1.01-1.03;P<0.001)。
- 膝上截肢对比膝下截肢(HR 1.76,95%CI 1.39-2.25;P<0.001)。
- 急诊截肢对比择期(HR 8.59,95%CI 3.12-17.84;P<0.001)。
- 慢性肾脏病(HR 1.37,95%CI 1.04-1.80;P=0.026)、终末期肾病(HR 1.41,95%CI 1.00-1.98;P=0.048)、冠心病(HR 1.36,95%CI 1.08-1.71;P=0.010)。
临床怎么用
- 对考虑大截肢的CLTI或严重感染患者,应综合评估年龄、截肢平面、手术时机及合并症以进行预后判断。
- 医患沟通中可参考本研究生存数据,辅助共享决策。
局限性
- 单中心回顾性设计,结果外推需谨慎。
- 中位随访仅1.2年,长期生存数据可能不完整。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Previous studies have reported poor survival rates after major amputation for dysvascular or infected limbs. In this study, we examined contemporary long-term survival rates and causes of death among patients undergoing major lower extremity amputation. METHODS: Institutional medical records were queried for patients undergoing either above knee (AKA) or below knee amputation (BKA) for chronic limb-threatening ischemia (CLTI) or severe infection from 2020 to 2023. Mortality rates were evaluated using Kaplan-Meier survival curves, and Cox proportional hazards models were constructed to identify risk factors. RESULTS: A total of 747 patients underwent major amputation over the 4-year period, with a median follow-up of 1.2 years. Median age was 65 years old and 62.7% were male sex. AKAs (n = 371, 49.7%) and BKAs (n = 376, 50.3%) were evenly distributed. The overall 30-day, 1-year, and 3-year survival rates were 91.9% (95% confidence interval [CI], 89.9-93.9%), 72.8% (95% CI, 69.4-76.2%), and 49.0% (44.3-53.7%), respectively. Amputation-related causes of death comprised 15.9% of all patient mortalities, with a median interval of 24 postoperative days (interquartile range, 8-64). Risk factors for overall mortality included patient age (hazard ratio [HR], 1.02 per year, 95% CI, 1.01-1.03; P < 0.001), AKA (versus BKA; HR, 1.76, 95% CI, 1.39-2.25; P < 0.001), emergent amputation (versus elective; HR, 8.59, 95% CI, 3.12-17.84; P < 0.001), chronic kidney disease (HR, 1.37, 95% CI, 1.04-1.80; P = 0.026), end-stage renal disease (HR, 1.41, 95% CI, 1.00-1.98; P = 0.048), and coronary artery disease (HR, 1.36, 95% CI, 1.08-1.71; P = 0.010). CONCLUSION: Long-term mortality rates remain substantial among patients undergoing major lower extremity amputation. However, only a small fraction of these deaths are attributable to the amputation procedure or postoperative complications. Risk factors for overall mortality include advanced patient age, emergent operation, and the presence of significant medical comorbidities. These findings highlight the importance of comprehensive risk assessment and may aid in prognostication and shared decision-making for patients with CLTI or severe infection considering major amputation.
引用
- Kim Y, Yu J, Lew J, et al. Long-Term Mortality after Major Lower Extremity Amputation for Dysvascular or Infected Limbs. Ann Vasc Surg. 2026. PMID: 42833580. doi:10.1016/j.avsg.2026.09.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。